Zhao H - Search Results

1

SIRT2 inhibitor SirReal2 enhances anti-tumor effects of PI3K/mTOR inhibitor VS-5584 on acute myeloid leukemia cells.

Luo Y, Zhao H, Zhu J, Zhang L, Zha J, Zhang L, Ding Y, Jian X, Xia J, Xu B, Qi Z. Luo Y, et al. Among authors: zhao h. Cancer Med. 2023 Sep;12(18):18901-18917. doi: 10.1002/cam4.6480. Epub 2023 Sep 1. Cancer Med. 2023. PMID: 37658623 Free PMC article.

2

Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.

Zhao H, Shi P, Deng M, Jiang Z, Li Y, Kannappan V, Wang W, Li P, Xu B. Zhao H, et al. Oncotarget. 2016 Dec 20;7(51):85515-85528. doi: 10.18632/oncotarget.13454. Oncotarget. 2016. PMID: 27888802 Free PMC article.

3

CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.

Deng M, Shi Y, Chen K, Zhao H, Wang Y, Xie S, Zhao J, Luo Y, Fang Z, Fan Y, Xu B. Deng M, et al. Among authors: zhao j, zhao h. Exp Cell Res. 2018 Aug 15;369(2):356-362. doi: 10.1016/j.yexcr.2018.05.038. Epub 2018 Jun 1. Exp Cell Res. 2018. PMID: 29864401

4

Impairment of Vα24-Jα18⁺Vβ11⁺ natural killer T cells in adult acute lymphoblastic leukemia patients.

Zhao H, Li Z, Xie S, Luo Y, Zhou Y, Deng M, Zeng H, Zhao J, Yu L, Xu B. Zhao H, et al. Among authors: zhao j. Exp Cell Res. 2019 Jan 1;374(1):69-75. doi: 10.1016/j.yexcr.2018.11.008. Epub 2018 Nov 12. Exp Cell Res. 2019. PMID: 30439366

5

IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway.

Wu K, Zhao H, Xiu Y, Li Z, Zhao J, Xie S, Zeng H, Zhang H, Yu L, Xu B. Wu K, et al. Among authors: zhao j, zhao h. Int Immunopharmacol. 2019 Apr;69:136-142. doi: 10.1016/j.intimp.2019.01.027. Epub 2019 Jan 29. Int Immunopharmacol. 2019. PMID: 30708194

6

CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models.

Deng M, Zhao H, Chen Q, Zhao J, Shi Y, Yu L, Fang Z, Xu B. Deng M, et al. Among authors: zhao j, zhao h. Eur J Pharmacol. 2019 Jun 15;853:193-200. doi: 10.1016/j.ejphar.2019.03.041. Epub 2019 Mar 27. Eur J Pharmacol. 2019. PMID: 30928630

7

Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.

Bi S, Chen K, Feng L, Fu G, Yang Q, Deng M, Zhao H, Li Z, Yu L, Fang Z, Xu B. Bi S, et al. Among authors: zhao h. Eur J Pharmacol. 2019 Jul 15;855:252-261. doi: 10.1016/j.ejphar.2019.05.020. Epub 2019 May 11. Eur J Pharmacol. 2019. PMID: 31085238

8

Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway.

Yang Q, Chen K, Zhang L, Feng L, Fu G, Jiang S, Bi S, Lin C, Zhou Y, Zhao H, Chen XL, Fu G, Xu B. Yang Q, et al. Among authors: zhao h. Cancer Lett. 2019 Oct 1;461:31-43. doi: 10.1016/j.canlet.2019.07.003. Epub 2019 Jul 10. Cancer Lett. 2019. PMID: 31301319

9

Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients.

Wu K, Feng J, Xiu Y, Li Z, Lin Z, Zhao H, Zeng H, Xia W, Yu L, Xu B. Wu K, et al. Among authors: zhao h. Int Immunopharmacol. 2020 Mar;80:106122. doi: 10.1016/j.intimp.2019.106122. Epub 2020 Jan 16. Int Immunopharmacol. 2020. PMID: 31955066

10

Apatinib exhibits cytotoxicity toward leukemia cells by targeting VEGFR2-mediated prosurvival signaling and angiogenesis.

Deng M, Zha J, Zhao H, Jia X, Shi Y, Li Z, Fu G, Yu L, Fang Z, Xu B. Deng M, et al. Among authors: zhao h. Exp Cell Res. 2020 May 1;390(1):111934. doi: 10.1016/j.yexcr.2020.111934. Epub 2020 Feb 29. Exp Cell Res. 2020. PMID: 32126236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,831 results

Search Page

Filters